Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,182.00    0.00 (0.00%)
Bid:
1,170.00
Ask:
1,200.00
Spread: 30.00 (2.564%)
Market Cap: £541.66m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

14 Aug 2014 09:30

RNS Number : 1263P
Cohort PLC
14 August 2014
 



14 August 2014

COHORT PLC (the "Company")

Director Shareholdings, Share Awards and Options

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

Director shareholdings

Yesterday, the Company was notified that the sale of shares to satisfy share option exercise costs took place on 12 August 2014 as follows:

Description

Ordinary Shares

Market Value(pence)

Sale by AS Thomis' wife

25,477

197.25 p

Sale by SR Walther

7,644

197.25 p

Sale by SR Walther's wife

7,643

197.25 p

Following all transactions to date, including those detailed below, and subject to the completion of ISA transfers announced on 5 August 2014, Mr Thomis' and Mr Walther's interests and that of their connected persons are as follows:

Director

Ordinary shares

% of the total issued share capital

AS Thomis

86,225

0.21

SR Walther

78,892

0.19

Grant of Share Awards

On 11 August 2014 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 ("Restricted Share Scheme") were granted to directors of the Company for nil consideration as follows:

Director

Number of sharesunder this award

Total number of unvested shares under the Restricted Share Scheme following grant

AS Thomis

19,342

20,556

SR Walther

15,595

17,196

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2014.

Grant of Share Options

On 11 August 2014 share options pursuant to the Cohort plc 2006 Share Option Scheme ("Unapproved") and the Approved Share Option Subplan ("Approved") were granted to directors of the Company as follows:

Director

Number of shares under this option

Exercise Price(pence)

Total number of shares under option following grant

AS Thomis - Unapproved

4,153

197.5

246,944

Approved

15,189

197.5

15,189

SR Walther - Unapproved

406

197.5

172,580

Approved

15,189

197.5

15,189

The options can be exercised between 12 August 2017 and 11 August 2024.

On 11 August 2014 share options pursuant to the Cohort plc Savings Related Share Option Scheme ("SAYE Scheme") were granted to directors of the Company as follows:

Director

Number of shares underthis option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,602

207.5

4,932

SR Walther

867

207.5

6,692

The options are made pursuant to three year savings contracts.

The total share options held under each scheme following grant as set out above includes the recent exercise of share options announced on 5 August 2014.

Ends

For further information, please contact

Cohort plc

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

+44 (0)118 909 0390

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins

+44 (0)20 3128 8100

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDIGXBBGSS
Date   Source Headline
16th Jul 20257:00 amRNSFinal Results
11th Jul 20259:00 amRNS-RInvestor Presentation
11th Jul 20257:00 amRNSNotice of Results
9th Jul 202512:11 pmRNSHolding(s) in Company
1st Jul 202511:00 amRNSTotal Voting Rights
29th May 20257:00 amRNSFull Year Trading Update
12th May 20253:59 pmRNSBlock Listing Application
6th May 20252:00 pmRNS-RContract Win (Replacement)
1st May 20259:00 amRNS-RContract win
1st May 20257:00 amRNSTotal Voting Rights
24th Apr 202512:12 pmRNSDirector/PDMR Shareholding
9th Apr 20253:05 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:41 amRNSBlock Listing Six Monthly Return
1st Apr 20259:58 amRNSTotal Voting Rights
31st Mar 202512:53 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:34 pmRNSTotal Voting Rights
24th Feb 20252:57 pmRNSBlock Listing Six Monthly Return
21st Feb 20252:18 pmRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
12th Feb 20257:00 amRNSMASS wins extension for JCAST training contract
10th Feb 20257:00 amRNS-RCohort presentation at Shares Spotlight Event
5th Feb 20257:00 amRNS-RInvestor Presentation via Engage Investor
3rd Feb 20255:00 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSCompletion of EM Solutions Acquisition
24th Jan 20257:00 amRNS-RInvestor Presentation
20th Jan 20257:30 amRNSCompletion date of EM Solutions Acquisition
14th Jan 20257:00 amRNSInterim Report 2024
9th Jan 20257:00 amRNSContract Win
6th Jan 202511:25 amRNSHolding(s) in Company
2nd Jan 20254:44 pmRNSTotal Voting Rights
24th Dec 20248:30 amRNSREVISED COMPLETION OF ACQUISITION
16th Dec 20249:52 amRNSHolding(s) in Company
11th Dec 20242:00 pmRNSHalf Year Results (Replacement)
11th Dec 20247:00 amRNSHalf Year Results
2nd Dec 20242:45 pmRNSTotal Voting Rights
28th Nov 202410:00 amRNSNotice of Half Year Results
21st Nov 202411:26 amRNSResult of the Placing
21st Nov 202411:17 amRNSResult of the Retail Offer
21st Nov 20247:01 amRNSProposed Retail Offer to raise up to £1 million
21st Nov 20247:00 amRNSProposed Placing to raise £40 million
21st Nov 20247:00 amRNSAcquisition of EM Solutions
12th Nov 20249:33 amRNSHolding(s) in Company
4th Nov 20245:42 pmRNSHolding(s) in Company
1st Nov 20245:06 pmRNSTotal Voting Rights
21st Oct 202412:18 pmRNSDirector/PDMR Shareholding
4th Oct 20243:21 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:22 amRNSBlock Listing Six Monthly Return
1st Oct 202411:19 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.